The Novato-based maker of biopharmaceutical treatments for rare diseases plans to release this year a new gene therapy for ...

The most recent trading session ended with Bristol Myers Squibb (BMY) standing at $59.62, reflecting a +1.39% shift from the previouse trading day's closing. The stock fell short of the S&P 500, which ...